1、A N N U A L R E P O R t 2 0 0 9ON THE COVER The people of Johnson&Johnson remain true to who we are,motivated by finding innovations that touch lives.For example,a simple blood test that captures,identifies and counts circulating tumor cells in patients with certain types of metastatic cancer can,al
2、ong with other tests,support physicians in making more informed patient care decisions.For Jesica Harrington,shown here with her family,even this little bit of information about her own fight offered hope.Read her story on page 10.In one of our most challenging years,the people of Johnson&Johnson de
3、livered results that were as impressive as any we have ever achieved.We are stronger today than a year ago,with outstanding new products,robust pipelines and talented peoplepeople who remain inspired and united by a common purpose.caring for others.C H A I R M A N S L E T T E R1C H A I R M A N S L E
4、 T T E R To Our ShareholdersAs I reflect on the year that just passed,and the decades since the founding of Johnson&Johnson in 1886,I can say without hesitation that the year 2009 was one of the most challenging in our history.Faced with significant patent expirations worth nearly$3 billion in sales
5、,the most severe global economic downturn many of us have ever experienced and increased competition across our markets,our people delivered results that were as impressive as any we have ever achieved.Fundamental beliefs embedded in Our Credo guided their decisions and actions.We delivered on our f
6、inancial commit-ments,continued to pursue long-term growth opportunities,and emerged stronger and well-positioned for sustainable growth.Through all this,the people of Johnson&Johnson remained inspired and united by a common purpose:caring for others.More than ever,we know that caring for the health